Plain-English translation of NCT07641517 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a Phase 2 trial testing a new medication called to see if it can help reduce knee pain caused by osteoarthritis. About 150 people will take part, and half will receive the actual medication while the other half will receive a placebo (a pill with no active ingredient). Researchers want to understand whether this treatment is safe and how well it works for chronic knee pain.
Osteoarthritis is a common form of arthritis that causes long-term knee pain and can make daily activities difficult. Current treatments don't work well enough for everyone, so doctors are searching for new options to help patients manage their pain more effectively.
You likely qualify if…
You likely don't qualify if…
If you join, you'll randomly receive either the new medication or a placebo in pill form to take by mouth. You'll attend study visits where researchers will check your knee pain, ask questions about your symptoms, and monitor your overall health and safety. The study is designed to collect information over several weeks or months to determine whether this treatment is both safe and effective for osteoarthritis pain.
AI-generated summary from trial data · Sep 4, 2026 · Not medical advice
United States